{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T16:20:28Z","timestamp":1786119628177,"version":"build-2736575974"},"reference-count":11,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2005,5]]},"DOI":"10.1097\/01.aog.0000160480.55365.a8","type":"journal-article","created":{"date-parts":[[2010,11,12]],"date-time":"2010-11-12T02:34:07Z","timestamp":1289529247000},"page":"1278-1280","source":"Crossref","is-referenced-by-count":6,"title":["Malignant Mixed M\u00fcllerian Tumor of the Uterus in a Patient Taking Raloxifene"],"prefix":"10.1097","volume":"105","author":[{"given":"Noah A.","family":"Goldman","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria M.","family":"de Los Angeles","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joan G.","family":"Jones","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gary L.","family":"Goldberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-41-20210126","first-page":"962","article-title":"Principles and practice of gynecologic oncology.","author":"Curtin","year":"1999"},{"issue":"suppl 4","key":"R2-41-20210126","doi-asserted-by":"crossref","first-page":"S49","DOI":"10.1016\/S0959-8049(00)00223-9","article-title":"Breast cancer prevention: results of the National Surgical Adjuvant Breast and Bowel Project (NSABP) breast cancer prevention trial (NSABP P-1: BCPT).","volume":"36","author":"Dunn","year":"2000","journal-title":"Eur J Cancer"},{"key":"R3-41-20210126","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1093\/jnci\/86.7.527","article-title":"Endometrial cancer in tamoxifen-treated breast cancer patients: findings from the National Surgical Adjuvant Breast and Bowel Project (NSABP) B-14.","volume":"86","author":"Fisher","year":"1994","journal-title":"J Natl Cancer Inst"},{"key":"R4-41-20210126","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1016\/S0140-6736(00)02677-5","article-title":"Risk and prognosis of endometrial cancer after tamoxifen for breast cancer. Comprehensive Cancer Centres\u2019 ALERT Group. Assessment of Liver and Endometrial cancer Risk following Tamoxifen.","volume":"356","author":"Bergman","year":"2000","journal-title":"Lancet"},{"key":"R5-41-20210126","doi-asserted-by":"crossref","first-page":"2189","DOI":"10.1001\/jama.281.23.2189","article-title":"The effect of raloxifene on risk of breast cancer in postmenopausal women: results from the MORE randomized trial. Multiple Outcomes of Raloxifene Evaluation.","volume":"281","author":"Cummings","year":"1999","journal-title":"JAMA"},{"key":"R6-41-20210126","first-page":"95","article-title":"A 12-month comparative study of raloxifene, estrogen, and placebo on the postmenopausal endometrium.","volume":"95","author":"Goldstein","year":"2000","journal-title":"Obstet Gynecol"},{"key":"R7-41-20210126","doi-asserted-by":"crossref","first-page":"2758","DOI":"10.1200\/JCO.2002.20.11.2758","article-title":"Association of tamoxifen and uterine sarcoma.","volume":"20","author":"Wickerham","year":"2002","journal-title":"J Clin Oncol"},{"key":"R8-41-20210126","doi-asserted-by":"crossref","first-page":"1122","DOI":"10.1093\/jnci\/94.15.1122","article-title":"FDA issues warning about \u2018new\u2019 tamoxifen risk.","volume":"94","author":"Twombly","year":"2002","journal-title":"J Natl Cancer Inst"},{"key":"R9-41-20210126","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1006\/gyno.1993.1118","article-title":"Role of prolonged stimulation of tamoxifen therapy in the etiology of endometrial sarcomas.","volume":"49","author":"Altaras","year":"1993","journal-title":"Gynecol Oncol"},{"key":"R10-41-20210126","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1046\/j.1471-0528.2003.02252.x","article-title":"A multicentre randomised trial to compare uterine safety of raloxifene with a continuous combined hormone replacement therapy containing oestradiol (E2) and norethisterone acetate.","volume":"110","author":"Neven","year":"2003","journal-title":"Br J Obstet Gynaecol"},{"key":"R11-41-20210126","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/S0015-0282(02)04409-6","article-title":"Growth effects of raloxifene, E2, medroxy-progesterone acetate, and progesterone on human endometrial adenocarcinoma cells.","volume":"79","author":"Boostanfar","year":"2003","journal-title":"Fertil Steril"}],"container-title":["Obstetrics &amp; Gynecology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/00006250-200505001-00041","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T18:45:32Z","timestamp":1786041932000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/00006250-200505001-00041"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,5]]},"references-count":11,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2005]]}},"URL":"https:\/\/doi.org\/10.1097\/01.aog.0000160480.55365.a8","relation":{},"ISSN":["0029-7844"],"issn-type":[{"value":"0029-7844","type":"print"}],"subject":[],"published":{"date-parts":[[2005,5]]}}}